Title: Overview of the new oral anticoagulants: opportunities and challenges.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20150501
Title: Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice.
Journal: The Journal of pharmacology and experimental therapeutics 20141101
Title: A specific antidote for dabigatran: functional and structural characterization.
Journal: Blood 20130502
Title: New oral anticoagulants: comparative pharmacology with vitamin K antagonists.
Journal: Clinical pharmacokinetics 20130201
Title: The effect of total hip/knee replacement surgery and prophylactic dabigatran on thrombin generation and coagulation parameters.
Journal: Thrombosis research 20121101
Title: Use of direct thrombin inhibitor for treatment of cerebral venous thrombosis.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20121101
Title: Intravenous thrombolysis in a stroke patient taking dabigatran.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20121101
Title: Dabigatran and left atrial appendage thrombus.
Journal: Journal of thrombosis and thrombolysis 20121101
Title: Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20121101
Title: The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice.
Journal: The Journal of pharmacology and experimental therapeutics 20121101
Title: Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis.
Journal: Thrombosis research 20121101
Title: Analysis of the projected utility of dabigatran, rivaroxaban, and apixaban and their future impact on existing Hematology and Cardiology Anticoagulation Clinics at The Johns Hopkins Hospital.
Journal: Journal of thrombosis and thrombolysis 20121101
Title: Hemorrhagic complications associated with dabigatran use.
Journal: Clinical toxicology (Philadelphia, Pa.) 20121101
Title: Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.
Journal: British journal of haematology 20121101
Title: Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery.
Journal: Thrombosis and haemostasis 20121101
Title: Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitor.
Journal: Thrombosis and haemostasis 20121101
Title: [Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests].
Journal: Therapeutische Umschau. Revue therapeutique 20121101
Title: [Clinical pharmacological aspects of new oral anticoagulants].
Journal: Therapeutische Umschau. Revue therapeutique 20121101
Title: Mechanical valve thrombosis with dabigatran.
Journal: Journal of the American College of Cardiology 20121023
Title: Prevention of stroke in patients with atrial fibrillation: anticoagulant and antiplatelet options.
Journal: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 20121001
Title: Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting.
Journal: PharmacoEconomics 20121001
Title: Adjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillation.
Journal: QJM : monthly journal of the Association of Physicians 20121001
Title: Determination of the anti-F10a or anti-F2a generation action of rivaroxaban or dabigatran.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20121001
Title: A comparison of bleeding complications post-ablation between warfarin and dabigatran.
Journal: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 20121001
Title: Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectiveness.
Journal: Thrombosis and haemostasis 20121001
Title: Home-monitoring of oral anticoagulation vs. dabigatran. An indirect comparison.
Journal: Thrombosis and haemostasis 20121001
Title: Dabigatran: laboratory monitoring.
Journal: Pathology 20121001
Title: New anticoagulants for stroke prophylaxis in atrial fibrillation: assessing the impact on medication adherence.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20121001
Title: Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20121001
Title: What did we learn from new oral anticoagulant treatment?
Journal: Thrombosis research 20121001
Title: Antithrombotic treatment of atrial fibrillation: new insights.
Journal: Thrombosis research 20121001
Title: Dabigatran in clinical practice.
Journal: Clinical therapeutics 20121001
Title: The new oral anticoagulants and the future of haemostasis laboratory testing.
Journal: Biochemia medica 20121001
Title: [Dabigatran etexilate in clinical practice for prevention of thromboembolic events in patients with atrial fibrillation].
Journal: Vnitrni lekarstvi 20121001
Title: The safety risks of innovation: the FDA's Expedited Drug Development Pathway.
Journal: JAMA 20120905
Title: Dabigatran etexilate in atrial fibrillation patients with severe renal impairment: dose identification using pharmacokinetic modeling and simulation.
Journal: Journal of clinical pharmacology 20120901
Title: Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin.
Journal: British journal of clinical pharmacology 20120901
Title: Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
Journal: Age and ageing 20120901
Title: Novel oral anticoagulation in management of venous thromboembolism, atrial fibrillation, and acute coronary syndrome.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20120901
Title: Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for use.
Journal: Journal of cardiovascular pharmacology and therapeutics 20120901
Title: Treatment of venous thromboembolism with dabigatran.
Journal: Current opinion in pulmonary medicine 20120901
Title: Evaluation of the acute coronary syndrome safety profile of dabigatran etexilate in patients undergoing major orthopedic surgery: findings from four Phase 3 trials.
Journal: Thrombosis research 20120901
Title: Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents.
Journal: Coronary artery disease 20120901
Title: Dabigatran etexilate: a pharmacoeconomic review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.
Journal: PharmacoEconomics 20120901
Title: The management of antithrombotic medication in skin surgery.
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20120901
Title: Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention.
Journal: Thrombosis and haemostasis 20120901
Title: An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Journal: Thrombosis and haemostasis 20120901
Title: Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation.
Journal: Thrombosis and haemostasis 20120901
Title: Reversal of dabigatran anticoagulation by prothrombin complex concentrate (Beriplex P/N) in a rabbit model.
Journal: Journal of thrombosis and haemostasis : JTH 20120901
Title: Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate.
Journal: Journal of thrombosis and haemostasis : JTH 20120901
Title: Safe use of hemodialysis for dabigatran removal before cardiac surgery.
Journal: The Annals of pharmacotherapy 20120901
Title: The novel oral anticoagulants: an update for the interventional radiologist.
Journal: AJR. American journal of roentgenology 20120901
Title: [The new anticoagulants - their role in secondary prevention of thromboembolism after stroke].
Journal: Therapeutische Umschau. Revue therapeutique 20120901
Title: National trends in oral anticoagulant use in the United States, 2007 to 2011.
Journal: Circulation. Cardiovascular quality and outcomes 20120901
Title: The promise of novel direct oral anticoagulants.
Journal: Best practice & research. Clinical haematology 20120901
Title: Perioperative management of dabigatran: the Nelson experience to date.
Journal: The New Zealand medical journal 20120824
Title: Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
Journal: Journal of the American College of Cardiology 20120821
Title: Danger ahead: watch out for indirect comparisons!
Journal: Journal of the American College of Cardiology 20120821
Title: Thrombosis of a mechanical heart valve despite dabigatran.
Journal: Annals of internal medicine 20120821
Title: A new era of antithrombotic therapy in patients with atrial fibrillation.
Journal: The American journal of the medical sciences 20120801
Title: Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials.
Journal: Thrombosis research 20120801
Title: Acute stroke management in patients taking dabigatran.
Journal: CNS neuroscience & therapeutics 20120801
Title: Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.
Journal: The American journal of cardiology 20120801
Title: The Food and Drug Administration decision not to approve the 110 mg dose of dabigatran: give us a way out.
Journal: The American journal of medicine 20120801
Title: Spontaneous ascending aortic intramural haematoma in a patient on dabigatran.
Journal: Interactive cardiovascular and thoracic surgery 20120801
Title: Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers.
Journal: Thrombosis and haemostasis 20120801
Title: Reverse engineering for new oral anticoagulants: non-specific reversal agents and the anticoagulant activity of dabigatran and rivaroxaban.
Journal: Thrombosis and haemostasis 20120801
Title: Fatal gastrointestinal hemorrhage after a single dose of dabigatran.
Journal: Clinical toxicology (Philadelphia, Pa.) 20120801
Title: Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Journal: International angiology : a journal of the International Union of Angiology 20120801
Title: Complications of anticoagulation.
Journal: Disease-a-month : DM 20120801
Title: [New oral anticoagulants for the prevention of stroke. Open questions in geriatric patients].
Journal: Zeitschrift fur Gerontologie und Geriatrie 20120801
Title: Emerging oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation.
Journal: Minerva cardioangiologica 20120801
Title: Atraumatic acute carpal tunnel syndrome in a patient taking dabigatran.
Journal: Orthopedics 20120801
Title: Periprocedural anticoagulant management.
Journal: Hospital practice (1995) 20120801
Title: The new oral anticoagulants: a challenge for hospital formularies.
Journal: Hospital practice (1995) 20120801
Title: Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
Journal: Circulation 20120717
Title: Anticoagulation, novel agents, and procedures: can we pardon the interruption?
Journal: Circulation 20120717
Title: Epistaxis associated with dabigatran in an elderly patient with reduced creatinine clearance.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120715
Title: Dabigatran: uncharted waters and potential harms.
Journal: Annals of internal medicine 20120703
Title: New oral anticoagulants for atrial fibrillation.
Journal: Circulation 20120703
Title: Thrombotic events after discontinuing dabigatran: rebound or resumption?
Journal: BMJ (Clinical research ed.) 20120703
Title: Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding.
Journal: Thrombosis and haemostasis 20120701
Title: Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.
Journal: Circulation. Cardiovascular quality and outcomes 20120701
Title: Evaluating and assessing dabigatran drug interactions.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20120701
Title: Dabigatran in recurrent deep vein thrombosis: when one-size does not fit all.
Journal: The Israel Medical Association journal : IMAJ 20120701
Title: Faculty of Consulting Physicians of South Africa (FCPSA): saving brain with dabigatran.
Journal: Cardiovascular journal of Africa 20120701
Title: Dabigatran: rational dose individualisation and monitoring guidance is needed.
Journal: The New Zealand medical journal 20120629
Title: Epidural hematoma and intraoperative hemorrhage in a spine trauma patient on Pradaxa (dabigatran).
Journal: Spine 20120615
Title: Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial.
Journal: Expert opinion on pharmacotherapy 20120601
Title: New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation.
Journal: Journal of internal medicine 20120601
Title: Anti-stroke prophylaxis--the ethics of collateral damage.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20120601
Title: Dabigatran: a new chapter in anticoagulation.
Journal: Cardiovascular & hematological agents in medicinal chemistry 20120601
Title: Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.
Journal: Stroke 20120601
Title: Long-term benefits of preventing venous thromboembolic events.
Journal: Current medical research and opinion 20120601
Title: Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable?
Journal: Expert opinion on pharmacotherapy 20120601
Title: Dabigatran versus warfarin after mechanical mitral valve replacement in the swine model.
Journal: Journal of investigative surgery : the official journal of the Academy of Surgical Research 20120601
Title: Current and future alternatives to warfarin for the prevention of stroke in atrial fibrillation.
Journal: Critical pathways in cardiology 20120601
Title: An audience with... Gregory Lip. Interview by Asher Mullard.
Journal: Nature reviews. Drug discovery 20120601
Title: Rectal bleeding and hemostatic disorders induced by dabigatran etexilate in 2 elderly patients.
Journal: The Annals of pharmacotherapy 20120601
Title: An anticoagulation option for nonvalvular atrial fibrillation.
Journal: The Journal of family practice 20120601
Title: Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Journal: Advances in therapy 20120601
Title: Dabigatran for the prevention of thromboembolic complications in the elderly: a RE-LY-able alternative to warfarin?
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20120601
Title: A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN).
Journal: American heart journal 20120601
Title: New anticoagulant fights for credibility.
Journal: Managed care (Langhorne, Pa.) 20120601
Title: Novel oral anticoagulants for stroke prevention in atrial fibrillation.
Journal: European heart journal 20120601
Title: [Series: Clinical study from Japan and its reflections RE-LY trial].
Journal: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20120510
Title: Dabigatran etexilate: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.
Journal: Drugs 20120507
Title: Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile.
Journal: European journal of clinical pharmacology 20120501
Title: Dabigatran efficacy-safety assessment for stroke prevention in patients with atrial fibrillation.
Journal: Journal of thrombosis and haemostasis : JTH 20120501
Title: Neurosurgical complications of direct thrombin inhibitors--catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran.
Journal: Journal of neurosurgery 20120501
Title: Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.
Journal: Thrombosis and haemostasis 20120501
Title: Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
Journal: Annals of neurology 20120501
Title: Hemopericardium in a patient treated with dabigatran etexilate.
Journal: Pharmacotherapy 20120501
Title: Fatal basilar artery occlusion under dabigatran occurring 13 days after femoral embolectomy.
Journal: Vascular and endovascular surgery 20120501
Title: Novel oral anticoagulants--key messages for the angiologist.
Journal: VASA. Zeitschrift fur Gefasskrankheiten 20120501
Title: Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management.
Journal: Wiener klinische Wochenschrift 20120501
Title: New oral anticoagulants: will they replace warfarin?
Journal: Oral surgery, oral medicine, oral pathology and oral radiology 20120501
Title: Oral anticoagulants for atrial fibrillation: Which one to choose?
Journal: Advance for NPs & PAs 20120501
Title: Newer oral anticoagulant agents: a new era in medicine.
Journal: Current cardiology reviews 20120501
Title: Prescribing trends for dabigatran etexilate in primary care.
Journal: Irish medical journal 20120501
Title: [The monitoring of application of dabigatran as a remedy of prevention of thromboembolic complications after hip joint arthroplasty].
Journal: Klinicheskaia laboratornaia diagnostika 20120501
Title: Dabigatran and dabigatran ethyl ester: potent inhibitors of ribosyldihydronicotinamide dehydrogenase (NQO2).
Journal: Journal of medicinal chemistry 20120426
Title: Avoiding adverse events with dabigatran by careful selection of eligible patients.
Journal: The Medical journal of Australia 20120416
Title: New medicines - urgent need to assess outcomes in special groups.
Journal: The Medical journal of Australia 20120416
Title: Endovascular therapy after stroke in a patient treated with dabigatran.
Journal: The Medical journal of Australia 20120416
Title: Thromboprophylaxis in patients older than 75 years or with moderate renal impairment undergoing knee or hip replacement surgery [corrected].
Journal: International orthopaedics 20120401
Title: Interpretation of point-of-care INR results in patients treated with dabigatran.
Journal: The American journal of medicine 20120401
Title: Clinical challenges in a patient with dabigatran-induced fatal hemorrhage.
Journal: The American journal of geriatric pharmacotherapy 20120401
Title: A combined pharmacometric analysis of dabigatran etexilate in healthy volunteers and patients with atrial fibrillation or undergoing orthopaedic surgery.
Journal: Thrombosis and haemostasis 20120401
Title: Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation.
Journal: Heart (British Cardiac Society) 20120401
Title: Plasma-diluted thrombin time to measure dabigatran concentrations during dabigatran etexilate therapy.
Journal: American journal of clinical pathology 20120401
Title: Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20120401
Title: Dabigatran etexilate: an oral direct thrombin inhibitor for the management of thromboembolic disorders.
Journal: Clinical therapeutics 20120401
Title: Thromboembolic prophylaxis in orthopedic surgery using dabigatran: an oral direct thrombin inhibitor.
Journal: Expert review of cardiovascular therapy 20120401
Title: Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
Journal: The Annals of pharmacotherapy 20120401
Title: Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients.
Journal: Oral surgery, oral medicine, oral pathology and oral radiology 20120401
Title: Anticoagulation for atrial fibrillation ablation: what is the optimal strategy?
Journal: Journal of the American College of Cardiology 20120327
Title: Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.
Journal: Journal of the American College of Cardiology 20120327
Title: Progress for stroke prevention with atrial fibrillation: emergence of alternative oral anticoagulants.
Journal: Circulation 20120327
Title: [Prophylaxis of stroke and embolisms in atrial fibrillation--what is new in the guidelines?].
Journal: MMW Fortschritte der Medizin 20120322
Title: Important data after drug approval: comment on 'Dabigatran association with higher risk of acute coronary events'.
Journal: Archives of internal medicine 20120312
Title: Dabigatran: do we have sufficient data?: comment on 'Dabigatran association with higher risk of acute coronary events'.
Journal: Archives of internal medicine 20120312
Title: Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials.
Journal: Archives of internal medicine 20120312
Title: Dabigitran and the radiology department.
Journal: Irish journal of medical science 20120301
Title: The use of dabigatran immediately after atrial fibrillation ablation.
Journal: Journal of cardiovascular electrophysiology 20120301
Title: What's a mother to do?
Journal: Journal of cardiovascular electrophysiology 20120301
Title: Dabigatran etexilate: what do hospitalists need to know?
Journal: Journal of hospital medicine 20120301
Title: Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.
Journal: Thrombosis and haemostasis 20120301
Title: Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatran.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20120301
Title: Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Journal: Stroke 20120301
Title: What's the 'go to' anticoagulant for stroke prevention in atrial fibrillation?
Journal: Thrombosis and haemostasis 20120301
Title: New directions in anticoagulation.
Journal: The American journal of medicine 20120301
Title: Dabigatran (Pradaxa).
Journal: AJNR. American journal of neuroradiology 20120301
Title: A new generation of oral direct anticoagulants.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20120301
Title: [Controversy. Dabigatran in the preventive treatment of embolic stroke: arguments in favour of its utilisation as a first-choice drug].
Journal: Revista de neurologia 20120301
Title: [Controversy. Dabigatran in the preventive treatment of embolic stroke: arguments against its utilisation as a first-choice drug].
Journal: Revista de neurologia 20120301
Title: Is dabigatran cost effective compared with warfarin for stroke prevention in atrial fibrillation? A critically appraised topic.
Journal: The neurologist 20120301
Title: Bleeding risk with dabigatran in the frail elderly.
Journal: The New England journal of medicine 20120301
Title: Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding.
Journal: Blood 20120301
Title: [Clinical studies, the interests and limits of using dabigatran in atrial fibrillation].
Journal: Journal de pharmacie de Belgique 20120301
Title: [Pharmacological sheet. Dabigatran, oral administration (Pradaxa)].
Journal: Journal de pharmacie de Belgique 20120301
Title: [Prevention of cardioembolic stroke].
Journal: Neurologia (Barcelona, Spain) 20120301
Title: [Dabigatran: a new therapeutic alternative in the prevention of stroke].
Journal: Neurologia (Barcelona, Spain) 20120301
Title: Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study.
Journal: Journal of the American College of Cardiology 20120227
Title: Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial.
Journal: Circulation 20120207
Title: Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
Journal: Blood 20120202
Title: Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment.
Journal: Neurocritical care 20120201
Title: Rivaroxaban for the prevention and treatment of venous thromboembolism.
Journal: Fundamental & clinical pharmacology 20120201
Title: Preventing cardioembolic stroke in atrial fibrillation with dabigatran.
Journal: Current neurology and neuroscience reports 20120201
Title: Lack of an antagonist to reverse the action of dabigatran.
Journal: QJM : monthly journal of the Association of Physicians 20120201
Title: Promise of factor Xa inhibition in atrial fibrillation.
Journal: Current cardiology reports 20120201
Title: First cascade Mitsunobu reactions for the synthesis of 2-benzoxazole-N-phenyl and 2-benzimidazole-N-phenyl derivatives.
Journal: Molecular diversity 20120201
Title: Stroke prevention in atrial fibrillation: do we still need warfarin?
Journal: Current opinion in neurology 20120201
Title: Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip or knee surgery: a NICE single technology appraisal.
Journal: PharmacoEconomics 20120201
Title: Pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects after oral administration of dabigatran etexilate.
Journal: Thrombosis and haemostasis 20120201
Title: A new approach with anticoagulant development: tailoring anticoagulant therapy with dabigatran etexilate according to patient risk.
Journal: Expert opinion on pharmacotherapy 20120201
Title: Twice daily dosing of dabigatran for stroke prevention in atrial fibrillation: a pharmacokinetic justification.
Journal: Current medical research and opinion 20120201
Title: Using anticoagulants to steer clear of clots.
Journal: Nursing 20120201
Title: Application of the RELY study to lifetime risks of atrial fibrillation: implications for spontaneous intracranial hemorrhage.
Journal: Neurosurgery 20120201
Title: The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War?
Journal: International journal of stroke : official journal of the International Stroke Society 20120201
Title: Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease.
Journal: Expert review of neurotherapeutics 20120201
Title: The oral thrombin inhibitor dabigatran: strengths and weaknesses.
Journal: Seminars in thrombosis and hemostasis 20120201
Title: Determination of dabigatran in human plasma samples.
Journal: Seminars in thrombosis and hemostasis 20120201
Title: Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Journal: Chest 20120201
Title: Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Journal: Chest 20120201
Title: Warfarin versus dabigatran: comparing the old with the new.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20120201
Title: Dabigatran product familiarisation programmes: who benefits, who shouldn't get it?
Journal: Internal medicine journal 20120201
Title: Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
Journal: Prescrire international 20120201
Title: Anticoagulant loses its lustre.
Journal: Lancet (London, England) 20120128
Title: Switching patients from warfarin to dabigatran therapy: to RE-LY or not to rely.
Journal: International journal of cardiology 20120126
Title: UPLC MS/MS assay for routine quantification of dabigatran - a direct thrombin inhibitor - in human plasma.
Journal: Journal of pharmaceutical and biomedical analysis 20120125
Title: [Expanded arsenal in atrial fibrillation: bye-bye marcumar?].
Journal: MMW Fortschritte der Medizin 20120119
Title: Hospital budget implications of substituting dabigatran for warfarin in an anticoagulation service.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20120101
Title: Thrombosis on a Mechanical Aortic Valve whilst Anti-coagulated With Dabigatran.
Journal: Heart, lung & circulation 20120101
Title: Clinical pharmacology basis of deriving dosing recommendations for dabigatran in patients with severe renal impairment.
Journal: Journal of clinical pharmacology 20120101
Title: Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation.
Journal: Journal of internal medicine 20120101
Title: Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
Journal: Acta neurochirurgica 20120101
Title: Effects of dabigatran in vitro on thrombin biomarkers by Calibrated Automated Thrombography in patients after ischemic stroke.
Journal: Journal of thrombosis and thrombolysis 20120101
Title: Concerns about studies investigating new anticoagulant drugs for stroke prevention in atrial fibrillation.
Journal: Journal of neurology 20120101
Title: [Anticoagulation in atrial fibrillation: a new era has begun].
Journal: Hamostaseologie 20120101
Title: Using dabigatran in patients with stroke: a practical guide for clinicians.
Journal: Stroke 20120101
Title: Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
Journal: The Annals of pharmacotherapy 20120101
Title: Dabigatran in clinical practice for atrial fibrillation with special reference to activated partial thromboplastin time.
Journal: Circulation journal : official journal of the Japanese Circulation Society 20120101
Title: ARISTOTLE RE-LYs on the ROCKET. What's new in stroke prevention in patients with atrial fibrillation?
Journal: Cardiology journal 20120101
Title: [Pharmacoeconomic analysis of dabigatran etexilate effectiveness in patients with nonvalvular atrial fibrillation].
Journal: Kardiologiia 20120101
Title: New antiplatelet and anticoagulant drugs.
Journal: General dentistry 20120101
Title: Anticoagulation prophylaxis in orthopedic surgery: an efficiency frontier approach.
Journal: Postgraduate medicine 20120101
Title: New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.
Journal: Vascular health and risk management 20120101
Title: I recently heard that there are alternative medications to the blood thinner warfarin. What are they, and how are they different?
Journal: DukeMedicine healthnews 20120101
Title: Monitoring of the effects of new-generation oral anticoagulants – what does it mean? – .
Journal: Circulation journal : official journal of the Japanese Circulation Society 20120101
Title: Improving prevention and treatment of venous thromboembolism: clinical trial results.
Journal: Journal of medical economics 20120101
Title: Exfoliative esophagitis and esophageal ulcer induced by dabigatran.
Journal: Endoscopy 20120101
Title: Cost-effectiveness of dabigatran etexilate for stroke prevention in non-valvular atrial fibrillation. Applying RE-LY to clinical practice in Denmark.
Journal: Journal of medical economics 20120101
Title: [Update on current care guidelines: atrial fibrillation].
Journal: Duodecim; laaketieteellinen aikakauskirja 20120101
Title: Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials.
Journal: Journal of medical economics 20120101
Title: Hitting back HIT.
Journal: Annals of cardiac anaesthesia 20120101
Title: Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the Netherlands.
Journal: Journal of medical economics 20120101
Title: [New antithrombotic drugs].
Journal: Duodecim; laaketieteellinen aikakauskirja 20120101
Title: [Dabigatran and emergency operation on a peritonitis patient].
Journal: Duodecim; laaketieteellinen aikakauskirja 20120101
Title: Dabigatran: a new anticoagulant for stroke prevention in patients with atrial fibrillation.
Journal: Missouri medicine 20120101
Title: Newer anticoagulants for the prevention of venous thromboembolism.
Journal: The National medical journal of India 20120101
Title: Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons.
Journal: BMJ (Clinical research ed.) 20120101
Title: Dabigatran for stroke prevention in atrial fibrillation.
Journal: Hamostaseologie 20120101
Title: Cost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillation.
Journal: PloS one 20120101
Title: Pharmacokinetic and clinical implications of dabigatran use in severe renal impairment for stroke prevention in nonvalvular atrial fibrillation.
Journal: The Annals of pharmacotherapy 20120101
Title: Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation.
Journal: Circulation journal : official journal of the Japanese Circulation Society 20120101
Title: Can dabigatran be an alternative periprocedural anticoagulation for atrial fibrillation ablation?
Journal: Circulation journal : official journal of the Japanese Circulation Society 20120101
Title: Hemopericardium and cardiac tamponade associated with dabigatran use.
Journal: The Annals of pharmacotherapy 20120101
Title: [New anticoagulants: dabigatran, rivaroxaban and apixaban].
Journal: Gaceta medica de Mexico 20120101
Title: Emerging anticoagulant therapies for atrial fibrillation: new options, new challenges.
Journal: Current medicinal chemistry 20120101
Title: [Comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation].
Journal: Kardiologiia 20120101
Title: Agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a patient with paroxysmal atrial fibrillation.
Journal: Internal medicine (Tokyo, Japan) 20120101
Title: No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic stroke.
Journal: PloS one 20120101
Title: Diffuse alveolar hemorrhage associated with dabigatran.
Journal: Internal medicine (Tokyo, Japan) 20120101
Title: [New oral anticoagulants for atrial fibrillation: a neurologist's view].
Journal: Nederlands tijdschrift voor geneeskunde 20120101
Title: The ps in therapeutics.
Journal: International journal of pharmaceutical compounding 20120101
Title: [Therapeutic approach to the bleeding in association with 'old' and 'new' anticoagulants].
Journal: Vnitrni lekarstvi 20120101
Title: [Anticoagulant therapy in connection with cardioversion in patients with atrial fibrillation].
Journal: Kardiologiia 20120101
Title: Interference of the new oral anticoagulant dabigatran with frequently used coagulation tests.
Journal: Clinical chemistry and laboratory medicine 20120101
Title: [Dabigatran therapy--perioperative management and interpretation of coagulation tests].
Journal: Hamostaseologie 20120101
Title: Bleeding with dabigatran (Pradaxa).
Journal: The Medical letter on drugs and therapeutics 20111212
Title: Thromboembolism prophylaxis with dabigatran leads to lower perioperative blood loss than with dalteparin in primary knee arthroplasty.
Journal: Archives of orthopaedic and trauma surgery 20111201
Title: Dabigatran in atrial fibrillation: pharmacology and clinical trials.
Journal: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 20111201
Title: New anticoagulants: moving on from scientific results to clinical implementation.
Journal: Annals of medicine 20111201
Title: Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.
Journal: Journal of medical toxicology : official journal of the American College of Medical Toxicology 20111201
Title: [New anticoagulants: 'efficacy and safety' or 'efficacy or safety'].
Journal: Journal des maladies vasculaires 20111201
Title: Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor.
Journal: Journal of cardiothoracic and vascular anesthesia 20111201
Title: Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran.
Journal: Stroke 20111201
Title: Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence.
Journal: Journal of thrombosis and haemostasis : JTH 20111201
Title: Dabigatran: a new oral anticoagulant.
Journal: Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses 20111201
Title: Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
Journal: Pharmacotherapy 20111201
Title: Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectiveness.
Journal: Pharmacotherapy 20111201
Title: [Pharmacologic heterogeneity of new anticoagulants].
Journal: Journal des maladies vasculaires 20111201
Title: [New treatments for venous thromboembolic disease].
Journal: Journal des maladies vasculaires 20111201
Title: Dabigatran versus warfarin for patients with non-valvular atrial fibrillation: is the patient the winner?
Journal: Australian nursing journal (July 1993) 20111201
Title: Acutely injured patients on dabigatran.
Journal: The New England journal of medicine 20111124
Title: Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial.
Journal: Annals of internal medicine 20111115
Title: Learning the respective roles of warfarin and dabigatran to prevent stroke in patients with nonvalvular atrial fibrillation.
Journal: Annals of internal medicine 20111115
Title: Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial.
Journal: European heart journal 20111101
Title: Redemption by RE-DEEM?
Journal: European heart journal 20111101
Title: Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA).
Journal: Thrombosis and haemostasis 20111101
Title: Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial.
Journal: Journal of thrombosis and haemostasis : JTH 20111101
Title: A new landscape for stroke prevention in atrial fibrillation: focus on new anticoagulants, antiarrhythmic drugs, and devices.
Journal: Stroke 20111101
Title: [New anticoagulants. Characteristics, monitoring and management of bleeding].
Journal: Medizinische Klinik, Intensivmedizin und Notfallmedizin 20111101
Title: [Expectation to and problems of thrombin inhibitor].
Journal: Rinsho shinkeigaku = Clinical neurology 20111101
Title: [New anticoagulants].
Journal: La Revue du praticien 20111101
Title: Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.
Journal: Circulation 20111011
Title: Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
Journal: Circulation 20111004
Title: Reversal of new oral anticoagulants.
Journal: Circulation 20111004
Title: Direct thrombin inhibitors.
Journal: British journal of clinical pharmacology 20111001
Title: Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinux.
Journal: British journal of clinical pharmacology 20111001
Title: Update on the management of atrial fibrillation: anticoagulation and medical therapy.
Journal: Current cardiology reports 20111001
Title: New anticoagulants: how to deal with treatment failure and bleeding complications.
Journal: British journal of clinical pharmacology 20111001
Title: Anticoagulating obese patients in the modern era.
Journal: British journal of haematology 20111001
Title: Drug-induced exanthem following dabigatran.
Journal: The Annals of pharmacotherapy 20111001
Title: Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials.
Journal: Orthopedics 20111001
Title: Dabigatran: will it change clinical practice?
Journal: Cleveland Clinic journal of medicine 20111001
Title: Should dabigatran replace warfarin for stroke prevention in AF?
Journal: Drug and therapeutics bulletin 20111001
Title: The new oral anticoagulants.
Journal: Clinical medicine (London, England) 20111001
Title: Apixaban for stroke prevention in atrial fibrillation: a review of the clinical trial evidence.
Journal: Hospital practice (1995) 20111001
Title: [Interpretation of hemostatic and fibrinolytic markers].
Journal: Rinsho byori. The Japanese journal of clinical pathology 20111001
Title: [Atrial fibrillation: what the GP needs to know].
Journal: MMW Fortschritte der Medizin 20110922
Title: A new era for anticoagulation in atrial fibrillation.
Journal: The New England journal of medicine 20110915
Title: New options in anticoagulation for atrial fibrillation.
Journal: The New England journal of medicine 20110908
Title: Dabigatran falsely elevates point of care international normalized ratio results.
Journal: The American journal of medicine 20110901
Title: Prevention of venous thromboembolism after major orthopedic surgery: indirect comparison of three new oral anticoagulants.
Journal: Journal of thrombosis and haemostasis : JTH 20110901
Title: Update on anti-coagulation in atrial fibrillation.
Journal: QJM : monthly journal of the Association of Physicians 20110901
Title: Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation.
Journal: The Nurse practitioner 20110901
Title: [Thromboembolic prophylaxis 2011: is warfarin on the wane?].
Journal: Giornale italiano di cardiologia (2006) 20110901
Title: Update on dabigatran for stroke prevention in atrial fibrillation.
Journal: Connecticut medicine 20110901
Title: Dabigatran: a review of clinical and pharmacoeconomic evidence.
Journal: Critical pathways in cardiology 20110901
Title: Direct thrombin inhibitors for the treatment of venous thromboembolism: analysis of the Dabigatran versus Warfarin clinical trial.
Journal: Seminars in vascular surgery 20110901
Title: New antithrombotic drugs and European approval processes.
Journal: Lancet (London, England) 20110820
Title: Dabigatran-induced rash.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110815
Title: Pros and cons of dabigatran.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110815
Title: Dabigatran etexilate: A novel oral direct thrombin inhibitor.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110815
Title: [The new Anticoagulants - Relevant Facts for the GP].
Journal: Praxis 20110810
Title: ['Xa-tra-xa': opportunities and open questions about new anticoagulants].
Journal: Praxis 20110810
Title: Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism.
Journal: European heart journal 20110801
Title: Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs.
Journal: Journal of thrombosis and haemostasis : JTH 20110801
Title: New anticoagulants for prevention of stroke in patients with atrial fibrillation.
Journal: Journal of cardiovascular electrophysiology 20110801
Title: [New concepts in the therapy of atrial fibrillation].
Journal: Deutsche medizinische Wochenschrift (1946) 20110801
Title: [Pharmacological and clinical profiles of the direct thrombin inhibitor dabigatran etexilate methane sulfate (Prazaxa(®)) ].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20110801
Title: Hospital-based clinical implications of the novel oral anticoagulant, dabigatran etexilate, in daily practice.
Journal: Hospital practice (1995) 20110801
Title: Dabigatran for stroke prevention in all patients with atrial fibrillation?
Journal: Pharmacotherapy 20110801
Title: Dabigatran in patients with nonvalvular atrial fibrillation.
Journal: Journal of the American College of Cardiology 20110726
Title: The use of dabigatran in elderly patients.
Journal: Archives of internal medicine 20110725
Title: New anticoagulant drugs among elderly patients is caution necessary?: Comment on 'The use of dabigatran in elderly patients'.
Journal: Archives of internal medicine 20110725
Title: Atrial fibrillation: outpatient presentation and management.
Journal: Circulation 20110705
Title: Novel oral anticoagulants in development: Dabigatran, Rivaroxaban, and Apixaban.
Journal: American journal of therapeutics 20110701
Title: S35972, a direct-acting thrombin inhibitor with high oral bioavailability and antithrombotic efficacy.
Journal: Journal of thrombosis and haemostasis : JTH 20110701
Title: Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.
Journal: Thrombosis and haemostasis 20110701
Title: Frontiers of anticoagulation therapy for atrial fibrillation.
Journal: Journal of cardiology 20110701
Title: Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
Journal: The Annals of pharmacotherapy 20110701
Title: [New anticoagulants in the prevention and treatment of venous thromboembolism].
Journal: Orvosi hetilap 20110619
Title: Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
Journal: Circulation 20110607
Title: Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves.
Journal: The Journal of thoracic and cardiovascular surgery 20110601
Title: Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.
Journal: Advances in therapy 20110601
Title: Prevention of atrial fibrillation complications with antiarrhythmic drugs: still an unmet need in clinical practice.
Journal: Expert opinion on pharmacotherapy 20110601
Title: New drugs 2011 part 2.
Journal: Nursing 20110601
Title: A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery.
Journal: Drug safety 20110601
Title: Atrial fibrillation: epidemiology, prognosis and therapy.
Journal: Minerva medica 20110601
Title: Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.
Journal: International angiology : a journal of the International Union of Angiology 20110601
Title: [Is the era from the end of warfarin?].
Journal: Medizinische Monatsschrift fur Pharmazeuten 20110601
Title: Dabigatran: a new option for anticoagulation in atrial fibrillation and venous thromboembolism.
Journal: Critical pathways in cardiology 20110601
Title: What are the emerging therapeutic alternatives to warfarin in stroke patients? How would the results of RE-LY benefit Pakistanis?
Journal: JPMA. The Journal of the Pakistan Medical Association 20110601
Title: Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
Journal: Circulation 20110531
Title: Anticoagulant options--why the FDA approved a higher but not a lower dose of dabigatran.
Journal: The New England journal of medicine 20110512
Title: Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: two observational studies in patients undergoing total hip or total knee replacement.
Journal: Thrombosis research 20110501
Title: Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.
Journal: Arthritis and rheumatism 20110501
Title: Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective.
Journal: Thrombosis and haemostasis 20110501
Title: Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease.
Journal: The Annals of pharmacotherapy 20110501
Title: [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Journal: Medecine sciences : M/S 20110501
Title: Ask the doctor. For several years, I have been taking warfarin because of atrial fibrillation. I recently suffered several nosebleeds, which took two days to control. The trauma of those episodes makes me want to swear off warfarin, but I am not sure what other options I have.
Journal: Harvard health letter 20110501
Title: Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Journal: Annals of internal medicine 20110419
Title: Dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Journal: Annals of internal medicine 20110419
Title: [Current and future therapies for prophylaxis of thromboembolism in atrial fibrillation].
Journal: MMW Fortschritte der Medizin 20110414
Title: Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Journal: Thrombosis and haemostasis 20110401
Title: What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
Journal: Thrombosis and haemostasis 20110401
Title: New insights on the role of direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery.
Journal: Thrombosis and haemostasis 20110401
Title: [Dabigatran, a new oral anticoagulant].
Journal: Brain and nerve = Shinkei kenkyu no shinpo 20110401
Title: Place of dabigatran in contemporary pharmacotherapy.
Journal: Pharmacotherapy 20110401
Title: Preventing postsurgical venous thromboembolism: pharmacological approaches.
Journal: Seminars in thrombosis and hemostasis 20110401
Title: Differences between the varicella vaccines; using dabigatran.
Journal: JAAPA : official journal of the American Academy of Physician Assistants 20110401
Title: 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
Journal: Circulation 20110315
Title: 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
Journal: Journal of the American College of Cardiology 20110315
Title: Changing anticoagulant paradigms for atrial fibrillation: dabigatran, apixaban and rivaroxaban.
Journal: Expert opinion on pharmacotherapy 20110301
Title: 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Journal: Heart rhythm 20110301
Title: [Should dabigatran or vitamin K antagonists be used in prevention of stroke in patients with atrial fibrillation?].
Journal: Revista clinica espanola 20110301
Title: Dabigatran as anticoagulant therapy for atrial fibrillation. Which patients should receive it, which patients may not need it, and other practical aspects of patient management.
Journal: Polskie Archiwum Medycyny Wewnetrznej 20110301
Title: Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial.
Journal: Expert review of cardiovascular therapy 20110301
Title: Anticoagulation: improve care quality or use new alternatives?
Journal: Lancet (London, England) 20110205
Title: Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data.
Journal: Pharmacology & therapeutics 20110201
Title: Stroke prevention in the high-risk atrial fibrillation patient: Medical management.
Journal: Current cardiology reports 20110201
Title: Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
Journal: Thrombosis and haemostasis 20110201
Title: Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison.
Journal: Journal of clinical pharmacy and therapeutics 20110201
Title: [Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate].
Journal: Journal des maladies vasculaires 20110201
Title: Atrial fibrillation in 2010: advances in treatment and management.
Journal: Nature reviews. Cardiology 20110201
Title: New anticoagulants: pharmacology and clinical studies.
Journal: Wiener medizinische Wochenschrift (1946) 20110201
Title: Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children.
Journal: Wiener medizinische Wochenschrift (1946) 20110201
Title: Next generation anticoagulants may push warfarin to the wayside.
Journal: Managed care (Langhorne, Pa.) 20110201
Title: Dabigatran etexilate: a possible replacement for heparinoids and vitamin K antagonists?
Journal: Hospital practice (1995) 20110201
Title: New drug offers warfarin alternative for atrial fibrillation. An immediate switch is right for some people, but not necessary for all.
Journal: Harvard heart letter : from Harvard Medical School 20110201
Title: New oral anticoagulants and outpatient prophylaxis of venous thromboembolism.
Journal: The American journal of managed care 20110201
Title: Characteristics of novel anticoagulants and potential economic implications.
Journal: The American journal of managed care 20110201
Title: Is it time to abandon warfarin and embrace oral direct thrombin inhibitors to prevent stroke in patients with atrial fibrillation?
Journal: Neurosurgery 20110201
Title: Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
Journal: Circulation 20110118
Title: New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty.
Journal: BMJ (Clinical research ed.) 20110118
Title: Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Journal: Annals of internal medicine 20110104
Title: Novel anticoagulants: new evidence for emerging drugs and their potential application in major lower limb surgery.
Journal: Current vascular pharmacology 20110101
Title: Factor Xa and thrombin as targets for new oral anticoagulants.
Journal: Thrombosis research 20110101
Title: Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism.
Journal: Annual review of medicine 20110101
Title: New drugs: dabigatran etexilate mesylate, fingolimod hydrochloride, and ulipristal acetate.
Journal: Journal of the American Pharmacists Association : JAPhA 20110101
Title: The difference between Tdap and DTaP; dabigatran versus warfarin.
Journal: JAAPA : official journal of the American Academy of Physician Assistants 20110101
Title: Dabigatran etexilate: a review of its use in the prevention of stroke and systemic embolism in patients with atrial fibrillation.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20110101
Title: New oral anticoagulants: should they replace heparins and warfarin?
Journal: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20110101
Title: Electrophysiology and adult congenital heart disease: advances and options.
Journal: Progress in cardiovascular diseases 20110101
Title: South African experts comment on FDA approval of dabigatran in atrial fibrillation.
Journal: Cardiovascular journal of Africa 20110101
Title: Comparing the 2010 North American and European atrial fibrillation guidelines.
Journal: The Canadian journal of cardiology 20110101
Title: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Journal: The Canadian journal of cardiology 20110101
Title: An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
Journal: Journal of medical economics 20110101
Title: Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation--sub-analysis in Japanese population in RE-LY trial.
Journal: Circulation journal : official journal of the Japanese Circulation Society 20110101
Title: Dabigatran etexilate: the first oral anticoagulant available in the United States since warfarin.
Journal: Cardiology in review 20110101
Title: New oral anticoagulants for venous thromboembolism prophylaxis in orthopaedic surgery.
Journal: Instructional course lectures 20110101
Title: Stroke prevention in atrial fibrillation.
Journal: Cardiovascular journal of Africa 20110101
Title: Stroke risk reduction: focus of the new ESC guidelines.
Journal: Cardiovascular journal of Africa 20110101
Title: Antithrombotic therapy in atrial fibrillation: evaluation and positioning of new oral anticoagulant agents.
Journal: Circulation journal : official journal of the Japanese Circulation Society 20110101
Title: Re-LY trial: new sub-analyses highlight stroke reduction in all types of non-valvular atrial fibrillation.
Journal: Cardiovascular journal of Africa 20110101
Title: Stroke prevention in nonvalvular atrial fibrillation.
Journal: Texas Heart Institute journal 20110101
Title: [Atrial fibrillation: novel possibilities of anticoagulant therapy in patients subjected to cardioversion].
Journal: Kardiologiia 20110101
Title: Drug name alert: potential for confusion between pradax and plavix.
Journal: Dynamics (Pembroke, Ont.) 20110101
Title: Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient.
Journal: Advances in surgery 20110101
Title: Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses.
Journal: BMJ (Clinical research ed.) 20110101
Title: Cost of dabigatran for atrial fibrillation.
Journal: BMJ (Clinical research ed.) 20110101
Title: Dabigatran.
Journal: AJNR. American journal of neuroradiology 20110101
Title: Wound problems following hip arthroplasty before and after the introduction of a direct thrombin inhibitor for thromboprophylaxis.
Journal: Hip international : the journal of clinical and experimental research on hip pathology and therapy 20110101
Title: [Dabigatran eteksilat new anticoagulant for the prevention of stroke in patients with atrial fibrillation without valvular lesions].
Journal: Kardiologiia 20110101
Title: Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20110101
Title: Fibrinolytic treatment of acute ischemic stroke for patients on new oral anticoagulant drugs.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20110101
Title: Pharmacological basis and clinical evidence of dabigatran therapy.
Journal: Journal of hematology & oncology 20110101
Title: Dabigatran emerges as safe and effective warfarin alternative. The recently approved drug is more expensive, but appears to be more predictable.
Journal: Heart advisor 20110101
Title: Stroke in atrial fibrillation--hope on the horizon?
Journal: Journal of the Royal Society, Interface 20101206
Title: [New oral anticoagulants: better than vitamin K antagonists?].
Journal: Der Internist 20101201
Title: Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.
Journal: Thrombosis and haemostasis 20101201
Title: First oral warfarin alternative approved in the US.
Journal: Nature reviews. Drug discovery 20101201
Title: New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors.
Journal: Clinics in chest medicine 20101201
Title: Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial.
Journal: The Lancet. Neurology 20101201
Title: Dabigatran in atrial fibrillation: balancing secondary stroke prevention against bleeding risk.
Journal: The Lancet. Neurology 20101201
Title: [Dabigatran induced exanthema].
Journal: Revista clinica espanola 20101201
Title: Warfarin or not.
Journal: The journal of the Royal College of Physicians of Edinburgh 20101201
Title: Advances in the treatment of atrial fibrillation.
Journal: Minerva cardioangiologica 20101201
Title: Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.
Journal: Circulation 20101130
Title: Use of dabigatran etexilate to reduce breast cancer progression.
Journal: Cancer biology & therapy 20101115
Title: Dabigatran etexilate (Pradaxa)--a new oral anticoagulant.
Journal: The Medical letter on drugs and therapeutics 20101115
Title: Dabigatran: the anticoagulant we have long expected?
Journal: Recent patents on cardiovascular drug discovery 20101101
Title: Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
Journal: Circulation. Cardiovascular quality and outcomes 20101101
Title: Intracerebral hemorrhage: Pick your poison.
Journal: Cleveland Clinic journal of medicine 20101101
Title: What's new in treating older adults?
Journal: Cleveland Clinic journal of medicine 20101101
Title: [Novel anticoagulants for stroke prevention in atrial fibrillation].
Journal: Deutsche medizinische Wochenschrift (1946) 20101101
Title: [Two new anticoagulants available in 2010--Dabigatran Etexilate and Rivaroxaban: expected progresses--raised problems].
Journal: Annales pharmaceutiques francaises 20101101
Title: New options for stroke prevention in atrial fibrillation.
Journal: The American journal of managed care 20101101
Title: Dabigatran v warfarin. Compare with higher standard.
Journal: BMJ (Clinical research ed.) 20101026
Title: The influence of direct thrombin inhibitors on the formation of platelet-leukocyte aggregates and tissue factor expression.
Journal: Thrombosis research 20101001
Title: Dabigatran offers the simplest solution for thromboprophylaxis after orthopaedic surgery in patients allergic to low-molecular-weight heparins.
Journal: British journal of haematology 20101001
Title: Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20101001
Title: Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
Journal: Cardiovascular therapeutics 20101001
Title: Dabigatran for stroke prevention in atrial fibrillation: from RE-LY to daily clinical practice.
Journal: Acta cardiologica 20101001
Title: [Medication of the month. Dabigatran etixilate (Pradaxa): an oral anticoagulant acting as a direct selective inhibitor of thrombin].
Journal: Revue medicale de Liege 20101001
Title: A new anticoagulant for a new era: review of recent data on dabigatran etexilate.
Journal: Clinical advances in hematology & oncology : H&O 20101001
Title: Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.
Journal: Lancet (London, England) 20100918
Title: Quality of anticoagulation control in atrial fibrillation.
Journal: Lancet (London, England) 20100918
Title: [Oral prevention of thromboembolism with rivaroxaban and dabigatran: are the newly approved drugs innovations in orthopaedic and trauma surgery? ].
Journal: Zeitschrift fur Orthopadie und Unfallchirurgie 20100901
Title: Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.
Journal: Thrombosis research 20100901
Title: Pooled analysis of trials may, in the presence of heterogeneity inadvertently lead to fragile conclusions due to the importance of clinically relevant variables being either hidden or lost when the findings are pooled.
Journal: Thrombosis research 20100901
Title: Dabigatran acylglucuronide, the major human metabolite of dabigatran: in vitro formation, stability, and pharmacological activity.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20100901
Title: Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?
Journal: The American journal of medicine 20100901
Title: In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves.
Journal: Thrombosis research 20100901
Title: [Advances in the prevention of cerebral ischaemia due to atrial fibrillation].
Journal: Neurologia (Barcelona, Spain) 20100901
Title: Warfarin: is the end nigh? Please?
Journal: The journal of the Royal College of Physicians of Edinburgh 20100901
Title: When a virtue becomes a problem. The new oral anticoagulants.
Journal: Journal of thrombosis and haemostasis : JTH 20100801
Title: Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
Journal: Thrombosis and haemostasis 20100801
Title: Dabigatran may not be an effective anticoagulant for haemodialysis.
Journal: Nephrology (Carlton, Vic.) 20100801
Title: Prevention of stroke in patients with atrial fibrillation: the role of new antiarrhythmic and antithrombotic drugs.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20100801
Title: New oral anticoagulant drugs in cardiovascular disease.
Journal: Thrombosis and haemostasis 20100701
Title: Clot prevention--common questions about medications.
Journal: Australian family physician 20100701
Title: Does dabigatran improve stroke prevention in atrial fibrillation? A rebuttal.
Journal: Journal of thrombosis and haemostasis : JTH 20100601
Title: Will direct thrombin inhibition change the boundaries of oral anti-coagulation?
Journal: QJM : monthly journal of the Association of Physicians 20100601
Title: Old versus new anticoagulants: focus on pharmacology.
Journal: Recent patents on cardiovascular drug discovery 20100601
Title: Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.
Journal: Thrombosis and haemostasis 20100601
Title: Dabigatran challenges warfarin's superiority for stroke prevention in atrial fibrillation.
Journal: Stroke 20100601
Title: Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation.
Journal: Expert opinion on pharmacotherapy 20100601
Title: Boehringer launches first direct thrombin inhibitor: dabigatran (Pradaxa).
Journal: Cardiovascular journal of Africa 20100601
Title: Drug and dietary interactions of the new and emerging oral anticoagulants.
Journal: International journal of clinical practice 20100601
Title: [New oral anticoagulants: prospects].
Journal: La Revue du praticien 20100520
Title: New anticoagulants for prevention and treatment of venous thromboembolism.
Journal: Current vascular pharmacology 20100501
Title: Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty.
Journal: Archives of orthopaedic and trauma surgery 20100501
Title: Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement.
Journal: The Cochrane database of systematic reviews 20100414
Title: Dabigatran etexilate: a new thrombin inhibitor.
Journal: The Medical journal of Australia 20100405
Title: Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor.
Journal: Journal of thrombosis and haemostasis : JTH 20100401
Title: Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study.
Journal: Clinical pharmacokinetics 20100401
Title: Insights from the dabigatran versus warfarin trial in patients with venous thromboembolism (the RE-COVER trial).
Journal: Expert opinion on pharmacotherapy 20100401
Title: Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: exploratory indirect comparison based on meta-analysis of pivotal clinical trials.
Journal: Croatian medical journal 20100401
Title: Dabigatran: ready for prime time?
Journal: Polskie Archiwum Medycyny Wewnetrznej 20100401
Title: Potential of new anticoagulants in patients with cancer.
Journal: Thrombosis research 20100401
Title: Dabigatran versus warfarin for venous thromboembolism.
Journal: The New England journal of medicine 20100318
Title: Dabigatran versus warfarin for venous thromboembolism.
Journal: The New England journal of medicine 20100318
Title: Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial.
Journal: Expert opinion on pharmacotherapy 20100301
Title: Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development.
Journal: Thrombosis and haemostasis 20100301
Title: DVT: a new era in anticoagulant therapy.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20100301
Title: [Preventing stroke by treating atrial fibrillation--new hope with dronedarone and dabigatran?].
Journal: Deutsche medizinische Wochenschrift (1946) 20100301
Title: New oral anticoagulants: a practical guide for clinicians.
Journal: Journal of thrombosis and thrombolysis 20100201
Title: Replacing aspirin and warfarin for secondary stroke prevention: is it worth the costs?
Journal: Current opinion in neurology 20100201
Title: Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism in patients aged over 75 years or with moderate renal impairment undergoing total knee or hip replacement.
Journal: Thrombosis and haemostasis 20100201
Title: [Dabigatran: a new therapeutic option for therapy and prophylaxis of thromboembolic diseases?].
Journal: Deutsche medizinische Wochenschrift (1946) 20100201
Title: [Current state and perspectives of pharmacological and non-pharmacological treatment of atrial fibrillation: overview].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20100201
Title: The ultimate anticoagulants?
Journal: Cardiovascular journal of Africa 20100201
Title: Atrial fibrillation: A promising new anticoagulant for stroke prevention.
Journal: Nature reviews. Cardiology 20100101
Title: [Dabigatran in the treatment of a morbidly obese patient with recurring venous thrombosis].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20100101
Title: New oral anticoagulants in development: potential for improved safety profiles.
Journal: Reviews in neurological diseases 20100101
Title: [Dabigatran versus warfarin in the treatment of acute venous thromboembolism. Results of the RE-COVER study].
Journal: Kardiologiia 20100101
Title: New options with dabigatran etexilate in anticoagulant therapy.
Journal: Vascular health and risk management 20100101
Title: [Cost-effectiveness analysis of methods for thromboprophylaxis after orthopedic surgery].
Journal: Khirurgiia 20100101
Title: Dabigatran and acute stroke thrombolysis.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20100101
Title: Dabigatran and stroke thrombolysis.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20100101
Title: [Anticoagulant therapy in cardiology: yesterday, today, tomorrow].
Journal: Kardiologiia 20100101
Title: Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review.
Journal: PharmacoEconomics 20100101
Title: New anticoagulants for the prevention of thromboembolism.
Journal: Current pharmaceutical design 20100101
Title: Pharmacologic properties of the new oral anticoagulants: a clinician-oriented review with a focus on perioperative management.
Journal: Current pharmaceutical design 20100101
Title: Managing bleeding complications in patients treated with the old and the new anticoagulants.
Journal: Current pharmaceutical design 20100101
Title: Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
Journal: Cerebrovascular diseases (Basel, Switzerland) 20100101
Title: Focus on 2010 ESC Congress: new ESC guidelines and data on dabigatran.
Journal: Cardiovascular journal of Africa 20100101
Title: Warfarin versus new agents: interpreting the data.
Journal: Hematology. American Society of Hematology. Education Program 20100101
Title: Dabigatran versus warfarin in patients with atrial fibrillation.
Journal: The New England journal of medicine 20091231
Title: Dabigatran versus warfarin in patients with atrial fibrillation.
Journal: The New England journal of medicine 20091231
Title: Dabigatran versus warfarin in patients with atrial fibrillation.
Journal: The New England journal of medicine 20091231
Title: Dabigatran versus warfarin in patients with atrial fibrillation.
Journal: The New England journal of medicine 20091231
Title: Dabigatran versus warfarin in patients with atrial fibrillation.
Journal: The New England journal of medicine 20091231
Title: Dabigatran versus warfarin in patients with atrial fibrillation.
Journal: The New England journal of medicine 20091231
Title: Dabigatran versus warfarin in the treatment of acute venous thromboembolism.
Journal: The New England journal of medicine 20091210
Title: [New oral anticoagulants. Consequences for perioperative coagulation diagnostics and therapy].
Journal: Der Anaesthesist 20091201
Title: At last, a RE-LYable alternative to warfarin for atrial fibrillation.
Journal: International journal of stroke : official journal of the International Stroke Society 20091201
Title: Oral anticoagulation with Factor Xa and thrombin inhibitors: Is there an alternative to warfarin?
Journal: Discovery medicine 20091201
Title: Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.
Journal: Arthritis and rheumatism 20091101
Title: [New drug in atrial fibrillation--how does it function in regular health care?].
Journal: Lakartidningen 20091101
Title: [The results of the RE-lY study promise more effective, safer and easier prevention of embolic complications in patients with non-valvular atrial fibrillation].
Journal: Vnitrni lekarstvi 20091101
Title: [Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians].
Journal: Journal des maladies vasculaires 20091101
Title: New agents for orthopaedic thromboprophylaxis: caution essential, but time will tell.
Journal: ANZ journal of surgery 20091101
Title: New anticoagulants and regional anesthesia.
Journal: Current opinion in anaesthesiology 20091001
Title: Anticoagulation with {blacktriangledown}dabigatran or{blacktriangledown}rivaroxaban.
Journal: Drug and therapeutics bulletin 20091001
Title: Dabigatran etexilate in venous thromboembolism.
Journal: Drugs of today (Barcelona, Spain : 1998) 20091001
Title: Can we rely on RE-LY?
Journal: The New England journal of medicine 20090917
Title: Dabigatran versus warfarin in patients with atrial fibrillation.
Journal: The New England journal of medicine 20090917
Title: [Stroke prevention in atrial fibrillation. Marcumar alternative in sight].
Journal: MMW Fortschritte der Medizin 20090917
Title: A logical approach to surgical thromboprophylaxis.
Journal: Current opinion in hematology 20090901
Title: Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal.
Journal: Health technology assessment (Winchester, England) 20090901
Title: [Dabigatran (Pradaxa): efficacy and safety].
Journal: Annales francaises d'anesthesie et de reanimation 20090901
Title: [Dabigatran: clinical pharmacology].
Journal: Annales francaises d'anesthesie et de reanimation 20090901
Title: Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits.
Journal: Journal of thrombosis and haemostasis : JTH 20090801
Title: What can ongoing clinical trials of anticoagulants demonstrate?
Journal: Journal of cardiovascular medicine (Hagerstown, Md.) 20090801
Title: New anticoagulants for atrial fibrillation.
Journal: Seminars in thrombosis and hemostasis 20090701
Title: [New agents for the prevention of venous thromboembolism].
Journal: Der Internist 20090601
Title: Dabigatran: new drug. Continue to use heparin, a better-known option.
Journal: Prescrire international 20090601
Title: Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran.
Journal: American heart journal 20090501
Title: [The new oral anticoagulant in the Netherlands].
Journal: Nederlands tijdschrift voor geneeskunde 20090418
Title: [New anticoagulants].
Journal: Deutsche medizinische Wochenschrift (1946) 20090401
Title: Should new oral anticoagulants replace low-molecular-weight heparin for thromboprophylaxis in orthopaedic surgery?
Journal: Archives of cardiovascular diseases 20090401
Title: The novel anticoagulants: entering a new era.
Journal: Swiss medical weekly 20090207
Title: Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.
Journal: The Journal of arthroplasty 20090101
Title: Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development.
Journal: Clinical pharmacokinetics 20090101
Title: Dabigatran etexilate for prevention of venous thromboembolism.
Journal: Thrombosis and haemostasis 20090101
Title: Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis.
Journal: Thrombosis and haemostasis 20090101
Title: Coadministration of dabigatran etexilate and atorvastatin: assessment of potential impact on pharmacokinetics and pharmacodynamics.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20090101
Title: In the pipeline: new oral anticoagulants for the prevention of venous thromboembolism.
Journal: Orthopedics 20090101
Title: Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery.
Journal: Clinical therapeutics 20090101
Title: New oral anticoagulants: not quite there yet.
Journal: Polskie Archiwum Medycyny Wewnetrznej 20090101
Title: Dabigatran etexilate: future directions in anticoagulant treatment.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20090101
Title: Dabigatran etexilate for the prophylaxis of venous thromboembolism after hip or knee replacement rationale for dose regimen.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20090101
Title: Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20090101
Title: Oral antithrombotic inhibitors: dabigatran etexilate, meeting an unmet need?
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20090101
Title: [Dabigatran and rivaroxaban, new oral anticoagulants for the treatment of venous thromboembolism].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101
Title: [Pharmacokinetics and pharmacodynamics of the new oral anticoagulants dabigatran and rivaroxaban].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20090101
Title: [From old to new anticoagulants: the role of the biologist].
Journal: Annales de biologie clinique 20090101
Title: New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?
Journal: PharmacoEconomics 20090101
Title: A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting.
Journal: PharmacoEconomics 20090101
Title: [Budget impact analysis of Pradaxa thromboprophylaxis after total hip or total knee replacement].
Journal: Therapie 20090101
Title: [Dabigatran versus Warfarin in patients with atrial fibrillation. Results of the RE-LY study].
Journal: Kardiologiia 20090101
Title: Dabigatran: safer, more effective and easier to use than warfarin.
Journal: Cardiovascular journal of Africa 20090101
Title: Prevention and treatment of thromboembolic events in medical patients and new anticoagulants.
Journal: Acta clinica Belgica 20090101
Title: [Thrombin inhibitor shows stable safety profile in the practice].
Journal: MMW Fortschritte der Medizin 20081211
Title: Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment.
Journal: Journal of clinical pharmacology 20081201
Title: Emergence of new oral antithrombotics: a critical appraisal of their clinical potential.
Journal: Vascular health and risk management 20081201
Title: Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.
Journal: Pharmacotherapy 20081101
Title: [Anaesthesia and thromboembolic disease].
Journal: Medicina clinica 20081101
Title: [New oral anticoagulants: molecular characteristics, mechanisms of action, pharmacokinetics and pharmacodynamics].
Journal: Medicina clinica 20081101
Title: New therapeutic option for thromboembolism--dabigatran etexilate.
Journal: Expert opinion on pharmacotherapy 20081001
Title: [Anticoagulation in atrial fibrillation].
Journal: Hamostaseologie 20081001
Title: [Always more amputations in Germany?].
Journal: Deutsche medizinische Wochenschrift (1946) 20081001
Title: Preventing venous thromboembolism through risk assessment approaches.
Journal: British journal of nursing (Mark Allen Publishing) 20080601
Title: New anticoagulant agents: direct thrombin inhibitors.
Journal: Cardiology clinics 20080501
Title: Prevention of venous thromboembolism in the geriatric patient.
Journal: Cardiology clinics 20080501
Title: New anticoagulants for treatment of venous thromboembolism.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20080301
Title: The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20080201
Title: Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa.
Journal: Seminars in thrombosis and hemostasis 20080201
Title: [Update in hospital internal medicine (2007): a selection].
Journal: Revue medicale suisse 20080130
Title: Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects.
Journal: Clinical pharmacokinetics 20080101
Title: Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate.
Journal: Clinical pharmacokinetics 20080101
Title: Dabigatran etexilate.
Journal: Drugs 20080101
Title: The top 4 advances in antithrombotic care in the last year.
Journal: Thrombosis research 20080101
Title: Brave new world: the current and future use of novel anticoagulants.
Journal: Thrombosis research 20080101
Title: New issues in oral anticoagulants.
Journal: Hematology. American Society of Hematology. Education Program 20080101
Title: Dabigatran versus enoxaparin after total hip replacement.
Journal: Lancet (London, England) 20071215
Title: Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.
Journal: Journal of thrombosis and haemostasis : JTH 20071101
Title: Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).
Journal: The American journal of cardiology 20071101
Title: Trials of venous thromboembolism prevention.
Journal: Lancet (London, England) 20070915
Title: Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
Journal: Lancet (London, England) 20070915
Title: The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.
Journal: British journal of clinical pharmacology 20070901
Title: Development of oral anticoagulants.
Journal: British journal of clinical pharmacology 20070901
Title: Dabigatran etexilate, a thrombin inhibitor for the prevention of venous thromboembolism and stroke.
Journal: Current opinion in investigational drugs (London, England : 2000) 20070901
Title: The new anticoagulants.
Journal: Perspectives in vascular surgery and endovascular therapy 20070901
Title: Effects of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate, on thrombus formation and bleeding time in rats.
Journal: Thrombosis and haemostasis 20070801
Title: Beyond unfractionated heparin and warfarin: current and future advances.
Journal: Circulation 20070731
Title: In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate.
Journal: Thrombosis and haemostasis 20070701
Title: Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosis.
Journal: Journal of thrombosis and haemostasis : JTH 20070601
Title: Population pharmacokinetic analysis of the new oral thrombin inhibitor dabigatran etexilate (BIBR 1048) in patients undergoing primary elective total hip replacement surgery.
Journal: Journal of clinical pharmacology 20070301
Title: New anticoagulants: from bench to bedside.
Journal: Hamostaseologie 20070201
Title: Agents to control bleeding show promise.
Journal: JAMA 20070124
Title: Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis.
Journal: British journal of clinical pharmacology 20061101
Title: Direct thrombin inhibitors.
Journal: The New England journal of medicine 20050908
Title: New anticoagulants.
Journal: Journal of thrombosis and haemostasis : JTH 20050801
Title: Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement.
Journal: Journal of clinical pharmacology 20050501
Title: A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.
Journal: Journal of thrombosis and haemostasis : JTH 20050101
Title: Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I.
Journal: Journal of thrombosis and haemostasis : JTH 20040901
Title: Oral direct thrombin inhibitors in clinical development.
Journal: Journal of internal medicine 20031001
Title: Structure-based design of novel potent nonpeptide thrombin inhibitors.
Journal: Journal of medicinal chemistry 20020425
Title: Wienen W, et al. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally activeprodrug, dabigatran etexilate. Thromb Haemost. 2007 Jul;98(1):155-62.
Title: Blair HA, Keating GM. Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation. Drugs. 2017;77(3):331-344.
